掌趣科技(300315.SZ):正在研發或調測的SLG產品包括《代號M》、《代號H》等
格隆匯5月16日丨掌趣科技(300315.SZ)於2023年5月16日15:00-17:00召開業績説明會,就“公司23年可以確保上線的遊戲有哪些?另外24年可以確保上線的遊戲儲備有哪些?”,公司回覆稱,公司正在研發或調測的SLG產品包括《代號M》、《代號H》等。2023年,在經過測試且數據達標後,公司計劃加大《代號M》的投放力度,並積極加快《代號H》的研發和上線。同時,在境內遊戲市場,公司在小遊戲市場積極探索,計劃通過自研小遊戲、成熟遊戲項目和在研遊戲項目新增研發小遊戲版本等方式,積極進軍小遊戲市場。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.